October 4, 2016
Daiichi Sankyo said on October 3 that it has kicked off company-initiated, large-scale registry research in Japan to study patients with non-valvular atrial fibrillation (NVAF) aged 75 and above. The research, dubbed ANAFIE (All Nippon AF In Elderly) Registry, is...read more